ArticleActa pharmacologica Sinica2023

Ceftazidime exhibits a broad inhibition to the infection of SARS-CoV-2 prototype and Omicron variant in vitro by blocking spike protein-ACE2 interaction.

Yun-Zhe Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.